FGF-23, which increases in parallel with the increase of phosphate levels from the early stages of chronic kidney disease, is known to contribute to the development of secondary hyperparathyroidism by leading to suppression of 1,25(OH)2 D levels and increased phosphate excretion [4]. Here, FGF23 is linked to secondary hyperparathyroidism.